Cancer Risk After Medical Treatment
Seiten
1991
Oxford University Press (Verlag)
978-0-19-261781-1 (ISBN)
Oxford University Press (Verlag)
978-0-19-261781-1 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
A comprehensive review of the evidence on cancers which may be caused (or prevented) by medical treatment for serious disease, including cancer itself. Covered are radiotherapy and chemotherapy, surgery and the special case of survivors of a first cancer in childhood.
"Cancer Risk After Medical Treatment" is a comprehensive review of recent research on cancer risk associated with various kinds of medical treatment. It covers radio-therapy and chemotherapy given for cancer and for other diseases, surgery, and the special case of survivors of a first cancer in childhood. It is aimed primarily at practising clinicians, to provide them with a review of cancer risks associated with the various treatment options available for serious disease, and to help them achieve the best balance of risk and benefit for each patient. It should also be of interest to research workers in epidemiology and basic clinical science for the insights it provides into cancer aetiology and the possibilities of devising more effective but less risky treatments. Perceptions of risk arising from medical treatment are often formed by rare but dramatic complications. This book provides a thorough and dispassionate review of all the evidence on one major group of diseases - the malignant neoplasms, or cancers - which may be caused by medical treatment, and sets these long-term but important risks against the immediate benefits obtained from the treatment.
"Cancer Risk After Medical Treatment" is a comprehensive review of recent research on cancer risk associated with various kinds of medical treatment. It covers radio-therapy and chemotherapy given for cancer and for other diseases, surgery, and the special case of survivors of a first cancer in childhood. It is aimed primarily at practising clinicians, to provide them with a review of cancer risks associated with the various treatment options available for serious disease, and to help them achieve the best balance of risk and benefit for each patient. It should also be of interest to research workers in epidemiology and basic clinical science for the insights it provides into cancer aetiology and the possibilities of devising more effective but less risky treatments. Perceptions of risk arising from medical treatment are often formed by rare but dramatic complications. This book provides a thorough and dispassionate review of all the evidence on one major group of diseases - the malignant neoplasms, or cancers - which may be caused by medical treatment, and sets these long-term but important risks against the immediate benefits obtained from the treatment.
Risk and benefit; radiation treatment for cancer - the induction of second malignancies; cancer after irradiation for non-malignant conditions; second malignancies following cytotoxic chemotherapy for cancer; chemotherapy and immunosuppression for non-malignant conditions; childhood malignancy; surgery; reducing the risk.
| Erscheint lt. Verlag | 1.8.1991 |
|---|---|
| Zusatzinfo | 1 halftone, line drawings, tables, bibliography |
| Verlagsort | Oxford |
| Sprache | englisch |
| Maße | 150 x 230 mm |
| Gewicht | 490 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie | |
| ISBN-10 | 0-19-261781-8 / 0192617818 |
| ISBN-13 | 978-0-19-261781-1 / 9780192617811 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
ein überfälliges Gespräch zu einer Pandemie, die nicht die letzte …
Buch | Hardcover (2024)
Ullstein Buchverlage
CHF 34,95
